MNKD

MannKind Corporation News Headlines

$6.52
*  
0.30
4.4%
Get MNKD Alerts
*Delayed - data as of Feb. 27, 2015  -  Find a broker to begin trading MNKD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
MannKind And Afrezza's NDA Evaluation: What Is The Real Justification For The Advisory Committee?
3/27/2014 6:23:00 PM - Seeking Alpha


MannKind And Afrezza's NDA Evaluation: What Is The Real Justification For The Advisory Committee?
3/27/2014 6:22:00 PM - Seeking Alpha


Pharma & Biotech Stock Outlook - March 2014 - Industry Outlook
3/26/2014 1:17:00 AM - Investopedia


Fear, Greed, And Prudent Risks: A Clarion Call To The Keepers Of The MannKind Flame
3/24/2014 3:24:00 PM - Seeking Alpha


MannKind: Follow The Smart Money
3/10/2014 12:48:00 PM - Seeking Alpha


SA PRO: Top Long And Short Ideas, Thursday February 20
2/21/2014 7:30:00 AM - Seeking Alpha


Prana Biotechnology And MannKind Corp.: Bad News Obeys Its Own Special Laws
2/20/2014 12:33:00 PM - Seeking Alpha


Significant Upcoming Catalysts For These Biotechs Should Provide Alpha Opportunity
2/14/2014 8:30:00 AM - Seeking Alpha


Is There Investment Upside In The Future Of Treating Diabetes?
2/10/2014 8:01:00 AM - Seeking Alpha


Is The Healthcare Sector Pulling Back Or Crashing?
1/28/2014 5:40:00 AM - Seeking Alpha


Cramer's Lightning Round - Mannkind Is Too Hot For The Touch (1/27/14)
1/28/2014 5:10:00 AM - Seeking Alpha


MannKind Catalysts: Insights About Diabetes Care Metrics And Long-Term Complications
1/22/2014 5:45:00 PM - Seeking Alpha


3 Small Biotech Companies Poised For Big Growth In 2014
1/21/2014 1:07:00 PM - Seeking Alpha


Why MannKind Is My 2014 Short Pick In Healthcare
1/17/2014 1:58:00 PM - Seeking Alpha


The Next Home Run In Healthcare
1/13/2014 9:49:00 AM - Seeking Alpha


MannKind's Day Of Reckoning Is Getting Very Close
1/13/2014 9:33:00 AM - Seeking Alpha


MannKind Corporation: One Large Step For Shareholders, One Gigantic Step For Diabetics
1/6/2014 7:30:00 AM - Seeking Alpha


6 Doubles In A Row And 2014's Top Pick
12/13/2013 7:30:00 AM - Seeking Alpha


The Next Great Growth Companies On Big Pharma's Radar
11/4/2013 11:45:00 AM - Seeking Alpha


A Medical Doctor's Perspective On MannKind Corp.'s Revolutionary Diabetes Mellitus Treatments
10/31/2013 12:39:00 PM - Seeking Alpha


Biotech: Let's Make A Billion-Dollar Deal, Part 2
10/1/2013 3:00:00 PM - Seeking Alpha


Kelly Close: State Of Diabetes Treatment, Companies In The Sector And Challenges Patients Face
9/24/2013 6:51:00 PM - Seeking Alpha


Companies Race To Develop The Next Novel Blockbuster Diabetes Drug
9/22/2013 6:30:00 AM - Seeking Alpha


Biodel: Creating A Better, Faster Acting Insulin, The Next Big Thing For Diabetic Therapy
9/12/2013 10:55:00 AM - Seeking Alpha


MannKind Stock: High Risk, High Reward
8/29/2013 3:15:00 PM - Seeking Alpha